( A report back from Dr Matt Young - Liberating Medeco Inala from Hep C. A study of micro-elimination in primary care - Treating Hepatitis C in General Practice Forum)
Previously Inala had the highest prevalence of hepatitis C in Australia, including high numbers of patients with double genotype. However more than 55% of the patients were not referred for treatment and of the ones who were referred only few started the treatment. Some of the reasons for not starting treatment included cost, self-efficacy, fear of stigma and judgment from staff.
